Detalhe da pesquisa
1.
Toll-like receptor 4-dependent contribution of the immune system to anticancer chemotherapy and radiotherapy.
Nat Med
; 13(9): 1050-9, 2007 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-17704786
2.
Incomplete penetrance of the predisposition to medulloblastoma associated with germ-line SUFU mutations.
J Med Genet
; 47(2): 142-4, 2010 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-19833601
3.
Functional, structural, and genetic evaluation of 20 CDKN2A germ line mutations identified in melanoma-prone families or patients.
Hum Mutat
; 30(4): 564-74, 2009 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-19260062
4.
Analysis of the DND1 gene in men with sporadic and familial testicular germ cell tumors.
Genes Chromosomes Cancer
; 47(3): 247-52, 2008 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-18069663
5.
Clinical and molecular genetics of patients with the Carney-Stratakis syndrome and germline mutations of the genes coding for the succinate dehydrogenase subunits SDHB, SDHC, and SDHD.
Eur J Hum Genet
; 16(1): 79-88, 2008 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-17667967
6.
Features associated with germline CDKN2A mutations: a GenoMEL study of melanoma-prone families from three continents.
J Med Genet
; 44(2): 99-106, 2007 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-16905682
7.
Methylation-associated PHOX2B gene silencing is a rare event in human neuroblastoma.
Eur J Cancer
; 43(16): 2366-72, 2007 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-17765533
8.
BRCA1, BRCA2, TP53, and CDKN2A germline mutations in patients with breast cancer and cutaneous melanoma.
Fam Cancer
; 6(4): 453-61, 2007.
Artigo
em Inglês
| MEDLINE | ID: mdl-17624602
9.
[Oncogenetic consultation for breast cancer]. / Consultation d'oncogénétique pour le cancer du sein.
Presse Med
; 36(2 Pt 2): 357-63, 2007 Feb.
Artigo
em Francês
| MEDLINE | ID: mdl-17258685
10.
Impact of an information booklet on satisfaction and decision-making about BRCA genetic testing.
Eur J Cancer
; 42(7): 871-81, 2006 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-16563745
11.
Geographical variation in the penetrance of CDKN2A mutations for melanoma.
J Natl Cancer Inst
; 94(12): 894-903, 2002 Jun 19.
Artigo
em Inglês
| MEDLINE | ID: mdl-12072543
12.
BRAF as a melanoma susceptibility candidate gene?
Cancer Res
; 63(12): 3061-5, 2003 Jun 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-12810628
13.
Significant contribution of germline BRCA2 rearrangements in male breast cancer families.
Cancer Res
; 64(22): 8143-7, 2004 Nov 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-15548676
14.
Screening for TP53 rearrangements in families with the Li-Fraumeni syndrome reveals a complete deletion of the TP53 gene.
Oncogene
; 22(6): 840-6, 2003 Feb 13.
Artigo
em Inglês
| MEDLINE | ID: mdl-12584563
15.
Risk of secondary leukemia after a solid tumor in childhood according to the dose of epipodophyllotoxins and anthracyclines: a case-control study by the Société Française d'Oncologie Pédiatrique.
J Clin Oncol
; 21(6): 1074-81, 2003 Mar 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-12637473
16.
Melanocortin-1 receptor (MC1R) gene variants and dysplastic nevi modify penetrance of CDKN2A mutations in French melanoma-prone pedigrees.
Cancer Epidemiol Biomarkers Prev
; 14(10): 2384-90, 2005 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-16214921
17.
Common BRCA2 variants and modification of breast and ovarian cancer risk in BRCA1 mutation carriers.
Cancer Epidemiol Biomarkers Prev
; 14(1): 265-7, 2005 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-15668505
18.
A single Mediterranean, possibly Jewish, origin for the Val59Gly CDKN2A mutation in four melanoma-prone families.
Eur J Hum Genet
; 11(4): 288-96, 2003 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-12700603
19.
BRCA1 wild-type allele modifies risk of ovarian cancer in carriers of BRCA1 germ-line mutations.
Cancer Epidemiol Biomarkers Prev
; 12(2): 90-5, 2003 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-12582017
20.
The Li-Fraumeni syndrome.
Biochimie
; 84(1): 75-82, 2002 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-11900879